In the BioHarmony Drug Report Database
Deutetrabenazine
Austedo (dutetrabenazine) is a small molecule pharmaceutical. Dutetrabenazine was first approved as Austedo on 2017-04-03. Austedo’s patents are valid until 2036-03-07 (FDA).
Trade Name
|
Austedo |
|---|---|
Common Name
|
dutetrabenazine |
ChEMBL ID
|
CHEMBL3137326 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)